SCHEMBL5570604

SCHEMBL5570604

c1cc(N2CCNCC2)ccc1N1CCNCC1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 9/20 0.77
HTR3E A5X5Y0 4/20 0.77
HTR3B O95264 4/20 0.77
HTR3A P46098 4/20 0.77
HTR3D Q70Z44 4/20 0.77
HTR3C Q8WXA8 4/20 0.77
SIGMAR1 Q99720 4/20 0.77
ADRB2 P07550 1/20 0.70
NCF1 P14598 1/20 0.70
PLD1 Q13393 1/20 0.70
LTA4H P09960 4/20 0.63
ALDH1A1 P00352 2/20 0.63
KDM4E B2RXH2 1/20 0.63
LMNA P02545 1/20 0.63
SIRT6 Q8N6T7 1/20 0.63
HTR5A P47898 1/20 0.59
USP2 O75604 1/20 0.59
TSHR P16473 1/20 0.59
HSD17B10 Q99714 1/20 0.59
HTR6 P50406 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17276864 0.92 ADRB1 (0.68) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL15245011 0.92 ADRB1 (0.68) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL6094312 0.88 ADRB1 (0.63) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL894537 0.88 ADRB1 (0.63) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL219742 0.88 ADRB1 (1.00) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL23260236 0.88 ADRB1 (0.63) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL2232832 0.88 ADRB1 (0.63) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL81940 0.88 ADRB1 (1.00) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL531923 0.88 ADRB1 (0.63) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL40343 0.88 ADRB1 (0.63) ADRB1HTR3EHTR3BHTR3AHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025105341-A1 METAL PATTERNING MATERIAL, PENTAFLUOROSULFANYL COMPOUND, METAL PATTERNING THIN FILM, ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC APPARATUS, AND METAL PATTERN FORMING METHOD 東ソー株式会社 2025-05-22 WO disclosed
US-20230191366-A1 MATERIAL AND METHOD FOR CARBON DIOXIDE FIXATION KYOTO UNIVERSITY (JP) 2023-06-22 US disclosed
US-10858377-B2 Multivinylaminosilanes as branching agents for functionalized elastomeric polymers TRINSEO EUROPE GMBH (CH) 2020-12-08 US disclosed
US-10787562-B2 Silane-mediated enhancement of rubber storage stability TRINSEO EUROPE GMBH (CH) 2020-09-29 US disclosed
US-20200055881-A1 MULTIVINYLAMINOSILANES AS BRANCHING AGENTS FOR FUNCTIONALIZED ELASTOMERIC POLYMERS TRINSEO EUROPE GMBH (CH) 2020-02-20 US disclosed
EP-3059240-B1 Multivinylaminosilanes as branching agents for functionalized elastomeric polymers TRINSEO EUROPE GMBH (CH) 2019-10-30 EP disclosed
US-20190169406-A1 SILANE-MEDIATED ENHANCEMENT OF RUBBER STORAGE STABILITY TRINSEO EUROPE GMBH (CH) 2019-06-06 US disclosed
EP-3257869-B1 SILANE-MEDIATED ENHANCEMENT OF RUBBER STORAGE STABILITY TRINSEO EUROPE GMBH (CH) 2019-01-23 EP disclosed
US-20180030070-A1 Multivinylaminosilanes as Branching Agents for Functionalized Elastomeric Polymers TRINSEO EUROPE GMBH (CH) 2018-02-01 US disclosed
WO-2017216344-A1 SILANE-MEDIATED ENHANCEMENT OF RUBBER STORAGE STABILITY TRINSEO EUROPE GMBH (CH) 2017-12-21 WO disclosed
EP-3257869-A1 SILANE-MEDIATED ENHANCEMENT OF RUBBER STORAGE STABILITY Trinseo Europe GmbH (CH) 2017-12-20 EP disclosed
EP-3059240-A1 Multivinylaminosilanes as branching agents for functionalized elastomeric polymers Trinseo Europe GmbH (CH) 2016-08-24 EP disclosed
EP-1057815-B1 CYCLIC AMIDE COMPOUNDS KOWA CO (JP) 2007-09-05 EP disclosed
US-6645957-B2 Useful in preventing and treating allergic immunological diseases; treating asthma, atopic dermatitis, allergic rhinitis, inflammatory large bowel disease, contact dermatitis KOWA CO., LTD. (JP) 2003-11-11 US disclosed
US-20030096828-A1 Cyclic amide compound KOWA CO., LTD. (JP) 2003-05-22 US disclosed
US-6448242-B1 COMPOUND HAVING A STRONG INHIBITORY EFFECT ON THE PRODUCTION OF AN IGE ANTIBODY; ANTIALLERGENS KOWA CO., LTD. (JP) 2002-09-10 US disclosed
EP-1057815-A1 CYCLIC AMIDE COMPOUNDS Kowa Co., Ltd. (JP) 2000-12-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200055881-A1 MULTIVINYLAMINOSILANES AS BRANCHING AGENTS FOR FUNCTIONALIZED ELASTOMERIC POLYMERS PRUNE1, GNE, TERB1 ADRB1 1387/4885HTR3E 1556/4885HTR3B 4073/4885
US-20030096828-A1 Cyclic amide compound CMA1, HRH2, HRH4 ADRB1 719/4885HTR3E 3631/4885HTR3B 3759/4885
US-20180030070-A1 Multivinylaminosilanes as Branching Agents for Functionalized Elastomeric Polymers GMNN, GNE, MSN ADRB1 1633/4885HTR3E 2643/4885HTR3B 4124/4885
US-20230191366-A1 MATERIAL AND METHOD FOR CARBON DIOXIDE FIXATION CPS1, CA4, CA13 ADRB1 4831/4885HTR3E 4876/4885HTR3B 4716/4885
US-10858377-B2 Multivinylaminosilanes as branching agents for functionalized elastomeric polymers GMNN, GNE, MSN ADRB1 1633/4885HTR3E 2643/4885HTR3B 4124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.